Sen. Cramer, Colleagues Push for Bipartisan Legislation to Make Oral Cancer Medications More Affordable

WASHINGTON — U.S. Senator Kevin Cramer (R-ND) joined a bipartisan group of senators in calling on House and Senate leadership to make sure the next coronavirus relief package includes their Cancer Drug Parity Act, which would make sure oral cancer drugs are covered in the same way as traditional intravenous (IV) chemotherapy.

You can access the letter here.